Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
22 May 2015 The European Medicines Agency Recommends Granting a Marketing Authorisation for Pembrolizumab Melanoma - Immuno-oncology
22 May 2015 The European Medicines Agency Recommends Granting a Marketing Authorisation for Nivolumab in Squamous NSCLC Lung and other thoracic tumours - Immuno-oncology - Anticancer agents & Biologic therapy
22 May 2015 WHO Model List of Essential Medicines Revised Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
18 May 2015 Annals of Oncology Press Release: World First – Researchers Quantify the Proportion of Different Genetic Mutations Contained within Individual Bowel Cancers Gastrointestinal cancers
15 May 2015 Results of a study presented at the ESMO World Congress on Gastrointestinal Cancer 2014 and the ESMO Congress 2014 published in The New England Jour...
12 May 2015 Lower Radiation Doses May Be Sufficient For Treating Certain Cancers, Report IAEA Experts Bioethics, legal and economic issues
08 May 2015 IMPAKT 2015 News: Molecular Screening of Patients with Metastatic Breast Cancer Can Be Carried-Out Across EU Countries Breast cancer - Personalised medicine
07 May 2015 IMPAKT 2015 News: Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: A Circulating Tumour Cell Liquid Biopsy May Be Used for Non-Invasive Mutational Analysis in Patients with Breast Cancer Breast cancer - Translational research
07 May 2015 IMPAKT 2015 News: PI3 Kinase and CDK4/6 Inhibitors Are Highly Active in ER-Positive Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: Incidence of Breast Cancer Oncogenes Higher in the PIK3K/AKT Signalling Pathway than in the MAPK Pathway Breast cancer - Translational research
07 May 2015 IMPAKT 2015 News: Using a Biomarker for Neoadjuvant Bevacizumab Response to Guide Treatment Is Cost Effective in Breast Cancer Breast cancer - Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: Analysis of Large Dataset Shows Improved Concordance of Local and Central HER2 Status Breast cancer - Pathology/Molecular biology
07 May 2015 IMPAKT 2015 News: AP-2gamma Tumour Expression Is a New Biomarker for Resistance to Endocrine Therapy in Patients with Metastatic Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: Outcome in Male Patients with Breast Cancer Varies According to Tumour Subtypes Based upon Receptor Expression Breast cancer